Tuesday, April 16, 2024

TOPICS

Home Tags Life Science

Tag: Life Science

EPIVAX AND CUBRC have been awarded a two-year, $1 million federal contract from the U.S. Food and Drug Administration to establish best practices and procedures for assessing generic peptides and related impurities for immunogenic potential. EpiVax CEO and Chief Science Officer Dr. Anne S. De Groot said generic peptides drugs are a quickly growing market. / PBN FILE PHOTO/MICHAEL SALERNO

EpiVax and CUBRC win $1M FDA contract to establish best practices...

PROVIDENCE – EpiVax Inc. and CUBRC Inc. have been awarded a two-year, $1 million federal contract from the U.S. Food and Drug Administration to...

Brown gift a big win for R.I.

Five years after a $15 million gift helped the University of Rhode Island establish the George and Anne Ryan Institute for Neuroscience, Brown University...
- Featured Event -

Latest News